Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease

BACKGROUND: Tangshen Formula (TSF) is a traditional Chinese medicine for the treatment of diabetic kidney disease (DKD). Liver-type fatty acid binding protein (L-FABP) is expressed in various tissues, including the kidney, where it is known as urinary L-FABP. Other studies demonstrated that urinary...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xin, Zhang, Bingxuan, Lu, Xiaoguang, Yan, Meihua, Wen, Yumin, Zhao, Tingting, Li, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962377/
https://www.ncbi.nlm.nih.gov/pubmed/27460780
http://dx.doi.org/10.1186/s12906-016-1228-4

Ejemplares similares

Ejemplares similares